Skip to main content
. 2022 Dec 30;17(12):e0278933. doi: 10.1371/journal.pone.0278933

Table 3. Estimated prevalence of HCV-Ab.

Absolute
number
Estimated prevalence
Weighted % 95% CI
Overall 1,927 1.57 0.45–5.30
Sex
Female 1,016 0.37 0.06–2.37
Male 1,001 2.85 0.71–10.71
Age (years)
1–4 342 0
5–9 179 0
10–14 120 0
15–19 328 0
20–24 122 0
25–29 185 0
30–34 167 3.78 0.45–25.62
35–39 115 0.71 0.09–5.52
40– 369 6.10 2.05–16.76
Place of residence (region)
Northern 525 0.72 0.18–2.90
Central 956 0.51 0.22–1.18
Southern 446 3.27 0.63–15.29
Ethnicity
Laoloum 1,121 0.87 0.38–1.96
Khmu 293 0
Hmong 322 1.14 0.20–6.15
Others 191 4.68 0.63–27.67
Operation history
Yes 122 0.90 0.10–7.45
No 1,805 1.62 0.45–5.62
Blood transfusion history
Yes 101 0.30 0.03–2.84
No 1,826 1.56 0.42–5.71
Sharing a toothbrush
Yes 107 0 -
No 1,820 1.68 0.48–5.70
Tattoo
Yes 133 1.08 0.23–4.96
No 1,794 1.99 0.56–6.79
Sharing a razor
Yes 49 0 -
No 1,878 1.97 0.57–6.55
Sharing needle for drug injection
Yes 47 4.78 0.81–23.46
No 1,880 1.80 0.46–6.75

HCV-Ab, hepatitis C antibody; CI, confidence interval.